Skip to main content

Advertisement

Log in

Generalized atherosclerosis sparing the transplanted kidney in Schimke disease

  • Brief Report
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

Schimke-immuno-osseous dysplasia (SIOD) is a multisystem disorder caused by a mutation of the chromatin remodeling protein. The main clinical findings are spondyloepiphyseal dysplasia with dysproportional growth deficiency, nephrotic syndrome with focal and segmental glomerulosclerosis, and defective cellular immunity. Transitory ischemic attacks due to vaso-occlusive processes are still an untreatable and life-limiting complication in patients with SIOD. The underlying pathophysiology of vaso-occlusive processes in SIOD is unclear. We report the clinical and pathological findings of the eldest published patient with the severe form of SIOD, who died at the age of 23 years due to pulmonary hypertension with subsequent right heart failure. The autopsy revealed a severe generalized atherosclerosis including the brain, heart, and pulmonary arteries. However, the kidney that was transplanted at the age of 5 years showed a good graft function without glomerular sclerosis and with only minimal nephrosclerosis on histology. Thus, the absence of severe vaso-occlusive processes in the transplanted organ and in the severely atherosclerotic host may indicate that the vaso-occlusive processes in SIOD are not caused by post-transplant cardiovascular morbidity such as arterial hypertension and hyperlipidemia. Instead, vascular factors of the host such as endothelial dysfunction may explain the pathophysiology of atherosclerosis in SIOD.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  1. Boerkoel CF, O’Neill S, Andre JL, Benke PJ, Bogdanovic R, Bulla M, Burguet A, Cockfield S, Cordeiro I, Ehrich JH, Frund S, Geary DF, Ieshima A, Illies F, Joseph MW, Kaitila I, Lama G, Leheup B, Ludman MD, McLeod DR, Medeira A, Milford DV, Ormala T, Rener-Primec Z, Weksberg R (2000) Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur J Pediatr 159:1–7

    CAS  PubMed  Google Scholar 

  2. Schimke RN, Horton WA, King CR (1971) Chondroitin-6-sulphate-uria, defective cellular immunity and nephritic syndrome. Lancet II:1088–1089

    Google Scholar 

  3. Schimke RN, Horton WA, King CR, Martin NL (1974) Chondroitin-6-sulphate mucopolysaccaridosis in conjunction with lymphopenia, defective cellular immunity and nephritic syndrome. Birth Defects 10:258–266

    CAS  PubMed  Google Scholar 

  4. Spranger J, Hinkel GK, Stoss H, Thoenes W, Wargowski D, Zepp F (1991) Schimke immuno-osseous dysplasia: a newly recognized multisystem disease. J Pediatr 119:64–72

    CAS  PubMed  Google Scholar 

  5. Ehrich JHH, Offner G, Schirg E, Hoyer PF, Helmchen U, Brodehl J (1990) Association of spondylo-epiphyseal dysplasia with nephrotic syndrome. Pediatr Nephrol 4:117–121

    CAS  PubMed  Google Scholar 

  6. Gilchrist DM, Harley FL (1992) Schimke immuno-osseous dysplasia. J Pediatr 120:497

    CAS  Google Scholar 

  7. Hashimoto K, Takeuchi A, Ieshima A, Takada M, Kasagi M (1994) Juvenile variant of Schimke immunoosseous dysplasia. Am J Med Genet 49:266–269

    CAS  PubMed  Google Scholar 

  8. Ehrich JHH, Burchert W, Schirg E, Krull F, Offner G, Hoyer PF, Brodehl J (1995) Steroid resistant nephrotic syndrome associated with spondyloepiphyseal dysplasia, transient ischemic attacks and lymphopenia. Clin Nephrol 43:89–95

    CAS  PubMed  Google Scholar 

  9. Schmidt B, Christen HJ, Herkenrath P, Benz-Bohm G, Muller-Berghaus J, Querfeld U (1997) Cerebral complications in Schimke immuno-osseous dysplasia. Eur J Pediatr 156:789–791

    Article  CAS  PubMed  Google Scholar 

  10. Boerkoel CF, Nowaczyk MJM, Blaser SI, Meschino WS, Weksberg R (1998) Schimke immunoosseous dysplasia complicated by moyamoya phenomenon. Am J Med Genet 78:118–122

    Article  CAS  PubMed  Google Scholar 

  11. Lücke T, Kemper M, Neumaier-Probst E, Bentele KHP, Spranger J, Kohlschütter A (1999) Das Moya-Moya-Phänomen bei der Immuno-Ossären Dysplasie Schimke. Monatsschr Kinderheilkd 147:904

    Google Scholar 

  12. Boerkoel CF, Takashima H, John J, Yan J, Stankiewicz P, Rosenbarker L, Andre JL, Bogdanovic R, Burguet A, Cockfield S, Cordeiro I, Frund S, Illies F, Joseph M, Kaitila I, Lama G, Loirat C, McLeod DR, Milford DV, Petty EM, Rodrigo F, Saraiva JM, Schmidt B, Smith GC, Spranger J, Stein A, Thiele H, Tizard J, Weksberg R, Lupski JR, Stockton DW (2002) Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat Genet 30:215–220

    Article  CAS  PubMed  Google Scholar 

  13. Da Fonseca MA (2000) Dental findings in the Schimke immuno-osseous dysplasia. Am J Med Genet 93:158–160

    Article  PubMed  Google Scholar 

  14. Dhillon AS, Chapman S, Milford DV (2001) Cerebellar defect associated with Schimke immuno-osseous dysplasia. Eur J Pediatr 160:372–374

    Article  CAS  PubMed  Google Scholar 

  15. Rodrigo F, Ferrer-Canabate J, Gracia S, Tovar I, Borraja E, Tellez C, Martinez P (2001) Schimke immunoosseous dysplasia syndrome (SIOD). Pediatr Nephrol 16:606–608

    Article  CAS  PubMed  Google Scholar 

  16. Iseki K, Fukiyama K (1996) Predictors of stroke in patients receiving chronic hemodialysis. Kidney Int 50:1672–1675

    CAS  PubMed  Google Scholar 

  17. Goldstein S, Duhamel G, Laudat MH, Berthelier M, Hervy C, Tete MJ, Broyer M (1984) Plasma lipids, lipoproteins and apolipoproteins AI, AII, and B in renal transplanted children: what risk for accelerated atherosclerosis? Nephron 38:87–92

    CAS  PubMed  Google Scholar 

  18. Kaitilia I, Savilahti E, Ormala T (1998) Autoimmune enteropathy in Schimke immunoosseous dysplasia. Am J Med Genet 77:427–430

    Article  PubMed  Google Scholar 

  19. Kim P, Jones JD, Sundt TM (1992) High-energy phosphate levels in the cerebral artery during chronic vasospasm after arachnoidal hemorrhage. Neurosurgery 76:991–996

    CAS  Google Scholar 

  20. Clark JF, Kemp GJ, Radda GK (1995) The creatine kinase equilibrium, free [ADP] and myosin ATPase in vascular smooth muscle. J Theor Biol 173:207–211

    Article  CAS  PubMed  Google Scholar 

  21. Moncada S, Higgs A (1993) The l-arginine-nitric oxide pathway. N Engl J Med 329:2002–2012

    CAS  PubMed  Google Scholar 

  22. Cooke JP, Dzau VJ (1997) Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 48:489–509

    CAS  PubMed  Google Scholar 

  23. Cayatte AJ, Palacino JJ, Horten K, Cohen RA (1994) Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits. Arterioscler Thromb 14:753–759

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Lücke.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lücke, T., Marwedel, K.M., Kanzelmeyer, N.K. et al. Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Pediatr Nephrol 19, 672–675 (2004). https://doi.org/10.1007/s00467-004-1426-z

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-004-1426-z

Keywords

Navigation